Awards Lumen Bioscience Teams with Google to Apply Machine Learning to Biologics ManufacturingLumen Bioscience | August 13, 2021Lumen Bioscience, a clinical-stage biopharmaceutical company developing products to treat and prevent highly prevalent diseases,…dcorriganAugust 13, 2021 Read More
Local News Researchers Pinpoint ‘Correlates of Protection’ for Moderna VaccineFred Hutch | August 13, 2021In the race to develop new and better vaccines and boosters to block COVID-19, scientists…dcorriganAugust 13, 2021 Read More
Publications of the Week Integrative Oncogene-Dependency Mapping Identifies RIT1 Vulnerabilities and Synergies in Lung CancerVichas, A. et al. | August 12, 2021CRISPR-based cancer dependency maps are accelerating advances in cancer precision medicine, but adequate functional maps…dcorriganAugust 12, 2021 Read More
Local News Curebase, Adaptive Biotechnologies Announce Collaboration to Expand Clinical Study AccessPR NewsWire | August 12, 2021Curebase, a company committed to democratizing access to clinical studies, and Adaptive Biotechnologies Corp. (Nasdaq: ADPT),…dcorriganAugust 12, 2021 Read More
Local News Eliem Is Latest Seattle-Area Biotech to Go Public, Raises $80M to Help Fuel Treatments for Nervous System DisordersGeekWire | August 11, 2021Eliem Therapeutics joined the ranks of publicly traded companies from Washington state, pricing 6.4 million shares…dcorriganAugust 11, 2021 Read More
Local News Kineta Announces Patent Issuance for U.S. Patent Covering Composition of Matter of KCP506, a Novel Non-Opioid Therapy for Chronic PainBioSpace | August 11, 2021Kineta Inc, through its subsidiary Kineta Chronic Pain LLC, announced today that the company has…dcorriganAugust 11, 2021 Read More
Local News Seeking to Expand Targeted Therapy for Lung CancerFred Hutch | August 11, 2021Targeted therapies have transformed outcomes for lung cancer patients. After reduced smoking rates, drugs that…dcorriganAugust 11, 2021 Read More
Local News Seagen and RemeGen Announce Exclusive Worldwide License and Co-Development Agreement for Disitamab VedotinSeagen, Inc. | August 10, 2021Seagen Inc., a world leader and pioneer in antibody-drug conjugate (ADC) therapies, and RemeGen Co.,…dcorriganAugust 10, 2021 Read More
Local News A Life Sciences Startup Will Base Its Headquarters in Both Seattle and California. It’s Far from the Only OneThe Seattle Times | August 10, 2021Sonoma Biotherapeutics, a life sciences company developing treatments for autoimmune diseases, announced this week it raised $265…dcorriganAugust 10, 2021 Read More
Publications of the Week A Rationally Designed C-Di-AMP FRET Biosensor to Monitor Nucleotide DynamicsPollock, A. J., et al. | August 10, 20213’3’-cyclic di-adenosine monophosphate (c-di-AMP) is an important nucleotide second messenger found throughout the bacterial domain…dcorriganAugust 10, 2021 Read More